Emergent Biosolutions Inc Stock CINNOBER BOAT
Stocks
0IGA
US29089Q1058
Pharmaceuticals
| Market Cap | 248M 215M 200M 184M 346M 23.62B 351M 2.35B 923M 11.84B 932M 912M 39.14B | P/E 2026 * |
-16.1x | P/E 2027 * | 5.32x |
|---|---|---|---|---|---|
| Enterprise Value | 248M 215M 200M 184M 346M 23.62B 351M 2.35B 923M 11.84B 932M 912M 39.14B | EV / Sales 2026 * |
0.36x | EV / Sales 2027 * | 0.28x |
| Free-Float |
43.95% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Emergent Biosolutions Inc
| Manager | Title | Age | Since |
|---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 70 | 21/02/2024 |
Richard Lindahl
DFI | Director of Finance/CFO | 62 | 26/03/2018 |
Simon Lowry
CTO | Chief Tech/Sci/R&D Officer | 53 | 18/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 01/04/2022 | |
Ronald Richard
BRD | Director/Board Member | 70 | 01/01/2005 |
Kathryn Zoon
BRD | Director/Board Member | 77 | 01/10/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 248M | |
| -0.52% | +3.21% | +89.52% | +127.32% | 1,057B | |
| +0.88% | +1.13% | +49.56% | +49.69% | 625B | |
| +0.89% | -1.95% | +24.23% | +64.44% | 435B | |
| +0.71% | +3.87% | +49.07% | +37.85% | 363B | |
| +0.64% | -0.49% | +33.94% | +40.01% | 296B | |
| +0.39% | -5.83% | +8.92% | +7.85% | 249B | |
| +1.51% | +6.69% | +42.58% | +57.57% | 222B | |
| +3.92% | -0.46% | -5.56% | -52.32% | 209B | |
| +1.80% | +2.30% | +11.56% | +66.35% | 165B | |
| Average | +1.02% | +0.87% | +33.76% | +44.31% | 402.31B | |
| Weighted average by Cap. | +0.66% | +1.22% | +48.72% | +64.63% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 693M 600M 560M 514M 966M 65.97B 982M 6.57B 2.58B 33.07B 2.6B 2.55B 109B | 892M 772M 721M 661M 1.24B 84.89B 1.26B 8.45B 3.32B 42.55B 3.35B 3.28B 141B |
| Net income | -15.87M -13.72M -12.82M -11.76M -22.11M -1.51B -22.46M -150M -59.02M -757M -59.58M -58.28M -2.5B | 47.92M 41.45M 38.71M 35.51M 66.79M 4.56B 67.85M 454M 178M 2.29B 180M 176M 7.56B |
| Net Debt | - | - |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
